Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
KBA1412
i
Other names:
KBA1412, AT1412
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
AIM Therap, Kling Bio
Drug class:
CD9 inhibitor
Related drugs:
‹
AT1412 (0)
AT1412 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
CD9 expression
Childhood B Acute Lymphoblastic Leukemia
CD9 expression
Childhood B Acute Lymphoblastic Leukemia
KBA1412
Sensitive: D – Preclinical
KBA1412
Sensitive
:
D
KBA1412
Sensitive: D – Preclinical
KBA1412
Sensitive
:
D
CD9 expression
B Acute Lymphoblastic Leukemia
CD9 expression
B Acute Lymphoblastic Leukemia
KBA1412
Sensitive: D – Preclinical
KBA1412
Sensitive
:
D
KBA1412
Sensitive: D – Preclinical
KBA1412
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login